KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Short term Debt (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Short term Debt for 16 consecutive years, with $4.1 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Short term Debt fell 14.16% year-over-year to $4.1 billion, compared with a TTM value of $4.1 billion through Sep 2024, down 14.16%, and an annual FY2023 reading of $3.6 billion, down 35.31% over the prior year.
  • Short term Debt was $4.1 billion for Q3 2024 at Thermo Fisher Scientific, down from $5.1 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $6.1 billion in Q2 2023 and bottomed at $2.0 million in Q3 2020.
  • Average Short term Debt over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2021.
  • The sharpest move saw Short term Debt tumbled 99.7% in 2020, then surged 46550.0% in 2022.
  • Year by year, Short term Debt stood at $2.6 billion in 2020, then dropped by 3.46% to $2.5 billion in 2021, then soared by 119.91% to $5.6 billion in 2022, then plummeted by 35.31% to $3.6 billion in 2023, then increased by 14.05% to $4.1 billion in 2024.
  • Business Quant data shows Short term Debt for TMO at $4.1 billion in Q3 2024, $5.1 billion in Q2 2024, and $4.5 billion in Q1 2024.